Article
Obesity weighs heavy on healthcare and human lives
Being overweight is not only bad for one’s health – it also costs society a lot of money. Every year, […] May 18, 2022 · SciMingo
Article
Indigo develops device to make light work of diabetes management
Ghent-based Indigo aims to make a huge difference to the quality of life of people with diabetes. The company is […] May 17, 2022 · BioVoxSpearhead cluster flanders.healthTech turns into MEDVIA and is ready to make a change in healthcare innovation
Ghent, Belgium, 17 May 2022 – With a strong new name and a sleek website, the industry-driven network MEDVIA aims at […] May 17, 2022 · Turnstone Communications
Article
Dualyx: restoring the body’s balance in autoimmune diseases
Belgian start-up Dualyx is developing a novel approach with the potential to treat a wide range of autoimmune disorders. The […] May 12, 2022 · V-Bio Ventures
News
Rejuvenate Biomed appoints life sciences leader Dr. Ajit Shetty as Chair of the Board of Directors to help guide international ambitions
Diepenbeek, Belgium, 12 May 2022 – Rejuvenate Biomed NV (“Rejuvenate”), a biomedical company developing novel combination drugs for age-related diseases, appoints […] May 12, 2022 · Turnstone CommunicationsAugustine Therapeutics appoints Gerhard Koenig as Chairman of the Board, forms Clinical Advisory Board, and broadens therapeutic indications
Leuven, Belgium, 10 May 2022 – Augustine Therapeutics, a biotech company developing novel therapies for neuromuscular and neurodegenerative disorders, appoints […] May 10, 2022 · Turnstone Communications
News
miDiagnostics launches its CE-IVD certified ultra-fast COVID-19 PCR test
Leuven, Belgium, 2 May 2022 – miDiagnostics, a fast-growing POC diagnostics company announces the launch of its CE-IVD certified ultra-fast COVID-19 PCR […] May 2, 2022 · Turnstone Communications
Article
IBA and SCK CEN partnership to produce rare radioisotope for cancer treatments
The radioisotope Actinium-225 shows clear promise in the battle against cancer, but to fulfil its potential we will need to […] April 20, 2022 · BioVox
Article
Drug development trends: from common to orphan indications… and back again?
Over the past few decades, pharma has gradually shifted its target patient focus for newly launched drugs from large to […] April 20, 2022 · V-Bio Ventures
Article
Genetic blindness: shining a light on Stargardt for future cures
The arrival of gene therapy in the ‘90s brought hope for the treatment of genetic diseases. In recent years, new […] April 20, 2022 · SciMingo
Article
VIB: a new focus on data science with Christine Durinx at the helm
Christine Durinx has been appointed as the new co-Managing Director of the world-class life sciences research institute VIB. Taking over […] April 20, 2022 · BioVox
News
Christine Durinx joins VIB as co-managing director
Belgium, 20 April 2022 – VIB and Flemish Minister of Economy and Innovation Hilde Crevits announce the appointment of Dr […] April 20, 2022 · Turnstone CommunicationsV-Bio Ventures raises EUR 110 million for its second fund and expands team
Ghent, Belgium, 31 March 2022 – V-Bio Ventures announced the final closing of its second fund, V-Bio Fund 2, having […] March 31, 2022 · V-Bio VenturesSolvay Brussels School of Economics and Management joins forces with the Belgian life sciences ecosystem to train the next generation of Biotech and MedTech leaders
Brussels, Belgium, 31 March 2022 — Today, the Solvay Brussels School of Economics and Management in collaboration with the ULB […] March 31, 2022 · Turnstone CommunicationsmiDiagnostics welcomes Nicolas De Clercq as its new Chief Financial Officer
Leuven, Belgium, 30 March 2022 – miDiagnostics, a fast-growing POC diagnostics company backed by Belgian Family Offices, announces today that Nicolas De […] March 30, 2022 · Turnstone CommunicationsRejuvenate Biomed Started a Groundbreaking Clinical Trial and Expands for Future Growth
• Started clinical trial with lead candidate RJx-01 for treating sarcopenia • Expands the team and moved to new offices and lab Diepenbeek, […] March 29, 2022 · Turnstone CommunicationsNew incubator biotope by VIB launches to support biotech startup teams on their journey to success
Ghent, Belgium, 24 March 2022 – Incubator program biotope by VIB launches today to support biotech startup teams looking to impact people’s lives through […] March 24, 2022 · Turnstone CommunicationsQbic announces first close of new fund at EUR 49 million to invest in spin-offs from world-class knowledge partners
St-Denijs-Westrem, Belgium, 17 March 2022 – Qbic, an inter-university venture capital fund focusing on the transformation of technological breakthroughs into […] March 17, 2022 · Turnstone Communications
Article
Antimicrobial Resistance – the hidden killer we’re ignoring
Antimicrobial Resistance has become an enormous challenge for global health, yet remains largely ignored by companies. As this deadly race […] March 16, 2022 · V-Bio Ventures
Article
Abscint labels antibodies with radioactive material to spot harmful cells
Abscint is one of several Belgian biotech companies using single-domain antibodies. But unlike the others, Abscint is using these antibodies […] March 16, 2022 · BioVox
Article
Eye implant from iSTAR Medical keeps glaucoma under control
Glaucoma is the leading cause of irreversible blindness, affecting around 100 million people worldwide. Good news though: the innovative implant […] March 16, 2022 · BioVox
Article
RE-Place project: Reducing animal research through alternative methods
If scientists could stop animal testing, most would do so immediately. So why is it taking so long to develop […] March 16, 2022 · SciMingoV-Bio Ventures’ Portfolio Company Precirix raises EUR 80 million in Series B to advance its pipeline of precision radiopharmaceuticals
Ghent, Belgium, 16 March 2022 – V-Bio Ventures today announced the completion of a EUR 80 million Series B round […] March 16, 2022 · V-Bio Venturesflanders.healthTech launches 14 unique innovation projects in healthcare
Ghent, Belgium, 10 March 2022 – Following the launch of the cluster flanders.healthTech in 2021, the first round of 14 […] March 10, 2022 · Turnstone CommunicationsV-Bio Ventures’ Portfolio Company Syndesi Therapeutics Acquired by AbbVie to Strengthen its Neuroscience Portfolio
Ghent, Belgium, 1 March 2022 – V-Bio Ventures today announced the completion of the acquisition of its portfolio company Syndesi […] March 1, 2022 · V-Bio VenturesmiDiagnostics ultra-fast COVID-19 PCR Test succeeds in Brussels Airport pilot study
Leuven, Belgium, 17 February 2022 – miDiagnostics, a fast-growing POC diagnostics company backed by Belgian Family Offices, announces the success of the […] February 17, 2022 · Turnstone Communications
News
SciMingo SciComm Academy launches spring program of workshops and lectures
The next couple of months, researchers can take part in science communication workshops organized by SciMingo, such as popular science […] February 16, 2022 · SciMingo
Article
Imitating nature: H2WIN’s innovative solution enables production of green hydrogen
Belgian GreenTech company H2WIN has developed H2GREEN: an ingenious system to make hydrogen production 100% renewable, more efficient, less expensive, […] February 16, 2022 · BioVox
Article
When should a biotech hire a CFO?
February 16, 2022 · V-Bio Ventures
Article
CRISPR takes the ‘bitter’ out of Belgian endives and chicory
Researchers have identified the bitter substances in Belgian endives and chicory. Using the gene-editing technique CRISPR/Cas9, they have also succeeded […] February 16, 2022 · BioVox
Article
Listening to chaos: could you control a hearing aid with your brain?
February 16, 2022 · SciMingoNewton Biocapital launches a new fund with initial capital commitments of EUR 50 million and target size of EUR 150 million
Brussels, Belgium, 15 February 2022 – Newton Biocapital (“Newton”), a life sciences investor, announces the launch of its new fund […] February 15, 2022 · Turnstone CommunicationsV-Bio Ventures raises additional capital to support young biotech companies
Ghent, Belgium, 27 January 2022 – V-Bio Ventures, a venture capital company that focuses specifically on the segment of young […] January 27, 2022 · V-Bio Ventures
Article
Economic Success: infinite growth is only possible in a diverse ecosystem
In recent public discussions on economic progress, people have been asking: is infinite growth really the best way to measure […] January 26, 2022 · V-Bio VenturesAnn Van Gysel appointed CEO of flanders.healthTech
Ghent, Belgium, 20 January 2022 – Dr. Ann Van Gysel has been appointed as CEO of the flanders.healthTech spearhead cluster. […] January 25, 2022 · Turnstone CommunicationsElmediX raises nearly 12 million euros to develop innovative heat technology to fight cancer
Mechelen, Belgium, January 25, 2022 – Belgian company ElmediX is developing intensive and controlled heat treatments for the treatment of […] January 25, 2022 · Turnstone Communications
Article
Belgium: The Health & Biotech Valley of Today and Tomorrow
As part of the ‘Health & Biotech Valley of Tomorrow’ initiative, the Belgian government recently signed a charter together with […] December 15, 2021 · BioVox
Article
Long COVID: what it means for the life sciences industry and other chronic conditions
Long COVID is a less talked-about aspect of the COVID-19 pandemic, yet its impact on society is already profound. Although […] December 15, 2021 · V-Bio Ventures
Article
Saving kidneys with a test that improves early detection of transplant rejection
All too often, kidney transplants fail because signs of a possible rejection remained unnoticed for too long. That’s why Belgian […] December 15, 2021 · BioVoxV-Bio Ventures participates in the EUR 12 million seed round of heart failure biotech Corteria Pharmaceuticals
Ghent, Belgium, 9 December 2021 – Corteria Pharmaceuticals, a French biotechnology company specialized in the development of interceptive therapies for heart […] December 9, 2021 · V-Bio Ventures
Article
Unlocking doors: Key considerations for start-ups during Discovery and Development
Mark Hicken is Vice President of Strategy for Europe, Middle East and Africa (EMEA) at the Janssen Pharmaceutical Companies of […] December 6, 2021 · Janssen PharmaceuticaNew start-up Trince raises EUR 4 million for innovative technology to produce personalized cancer therapies safer, cheaper, and faster
Ghent, Belgium, 6 December 2021 – Trince, a spin-off of Ghent University (UGent), is developing innovative and efficient technology to insert […] December 6, 2021 · Turnstone Communications
Sponsored
Rejuvenate Biomed: Expanding peoples’ health spans by boosting cell resilience
Aging will affect each and every one of us at some point; it is part of the covenant of life. […] November 24, 2021 · Turnstone Communications
Article
Confo-dently into the future!
Confo Therapeutics is a rising star in Belgium, featured on several local and international lists of up-and-coming biotechs. The company, […] November 24, 2021 · V-Bio Ventures
Article
International pharmaceutical consultant Amador Bioscience picks Belgium for its first European base
For its first European base, pharmaceutical consultant Amador Bioscience has chosen to set up shop in Limburg province, Belgium. The […] November 24, 2021 · BioVox
Article
Successes and setbacks for women’s health specialist Mithra
It has been a year with ups and downs for Mithra – the Liège-based specialist in women’s health. The company […] November 24, 2021 · BioVoxBelgium has all the ingredients to be a top country for data science in health – but we have to act now!
– Science for health will connect decisionmakers with researchers, clinicians, and company leaders on the topic of data science in healthcare – The event […] November 15, 2021 · Turnstone Communications
Article
Belgium has all the ingredients to be number one for real-world data in healthcare
Belgium is home to one of the world’s strongest health clusters and has long been ranked as the best country […] October 20, 2021 · BioVox
Article
Knowledge for Growth insights on sharing health data
Knowledge for Growth is Belgium’s largest life sciences conference, and with a mix of thought leaders from across the ecosystem, […] October 20, 2021 · BioVox
Article
New GMOs on the horizon: say ‘cheese’!
To meet the challenges of climate change and global food demand, more VCs are investing in AgTech companies. A lot […] October 20, 2021 · V-Bio Ventures
Article
The dark matter of the genome: Flamingo Therapeutics taps potential of mysterious RNA for cancer therapies
Things are moving fast for Flamingo Therapeutics, a Leuven-based biotech company developing innovative RNA-targeted cancer therapies. The start-up is a […] October 20, 2021 · BioVoxRejuvenate Biomed raises a EUR 15.7 million Series B to accelerate clinical development of its sarcopenia treatment for healthy aging
Heusden-Zolder, Belgium, Schlieren, Zürich, Switzerland, and Luxembourg, Grand Duchy of Luxembourg, 12 October 2021 – Rejuvenate Biomed NV (‘Rejuvenate’), a […] October 12, 2021 · Turnstone CommunicationsEsoBiotec ready to transform cell therapy cancer treatments
– EsoBiotec, a recently founded biotech company, announces a EUR 6 million pre-series A round comprised of non-dilutive funding from […] September 30, 2021 · Turnstone Communications
Article
Maccabi safely unlocks a treasure trove of health data for research insights
Progress in the use of patient healthcare data is going slow for most countries, but some are racing ahead and […] September 22, 2021 · BioVox
Sponsored
A vision of the future: smart contact lenses to treat patients with iris disorders and light sensitivity
A woman opens her front door and looks to the sky to judge the weather. It’s sunny and inside her […] September 22, 2021 · Turnstone Communications
Article
Fungi roots: the building blocks of a circular economy?
In the global search for more sustainable materials, one substance has recently begun attracting a lot of attention: mycelium, the […] September 22, 2021 · BioVox
Article
Biogen’s controversial Alzheimer’s drug approved by the FDA – what now?
It has been three months since the much-discussed FDA approval of Biogen’s Aduhelm, a treatment for Alzheimer’s Disease. The drug […] September 22, 2021 · V-Bio VenturesNewton Biocapital invests in PRISM BioLab to support development of a unique peptide mimetic technology platform to discover new drugs for intractable diseases
Brussels, Belgium / Tokyo, Japan – 9 September 2021 – Newton Biocapital (“Newton”), a life sciences investment fund active in […] September 9, 2021 · Turnstone Communications
Article
Why keeping up with data science matters for our health
Data without science is nothing; just 1s and 0s, floating around a cloud waiting for someone to make sense of […] August 18, 2021 · BioVox
Article
Cancer diagnosis and therapy in one: Precirix tackles tumors with camelid antibodies
A new drug that can identify tumors, trace metastases, and treat cancer – all in one? Belgian start-up Precirix is […] August 18, 2021 · V-Bio Ventures
Article
Betting on the best egg: Aurora test doubles pregnancy chances in assisted conception
Assisted conception techniques have matured in the last few decades, with Belgian scientists playing a big part in the progress. […] August 18, 2021 · BioVoxSpectricity Raises €14 Million Series B Funding as it Accelerates Plans to Deliver Industry Leading Hyperspectral Sensing to Mobile and Consumer Devices
Funding Expands Growth for Tiny Chip-size Sensors for Unimaginable New Applications. Mechelen, Belgium, August 3rd, 2021 – Spectricity, a leading provider of hyperspectral […] August 3, 2021 · Turnstone CommunicationsArdena’s success leads to major €35 million investment for expansion in Belgium, Sweden and The Netherlands
Ghent, Belgium, 14 July 2021 – Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organisation (CDMO), in partnership with GHO Capital, […] July 14, 2021 · Turnstone CommunicationsAzalea Vision closes € 8 million Series A to develop a smart contact lens for light sensitivity and ocular disorders
Azalea Vision develops autonomous smart solutions embedded inside a contact lens to improve the quality of life of people with […] July 8, 2021 · Turnstone CommunicationsNewton Biocapital invests in EditForce to support development of a unique DNA/RNA editing platform based on PPR protein technology
Brussels, Belgium / Tokyo, Japan – 1 July 2021 – Newton Biocapital (“Newton”), a life sciences investment fund active in […] July 1, 2021 · Turnstone Communications
Article
Moderna: from secretive platform company to vaccine superstar
Moderna Therapeutics has never really been a typical biotech. Sure, nowadays it is world famous thanks to its COVID-19 vaccine, […] June 23, 2021 · V-Bio Ventures
Article
Friend or foe: building a healthy relationship with your board
CEOs of start-ups face many challenges. Among many tasks, they have to set up the organization, write the business plan, […] June 23, 2021 · V-Bio VenturesNewton Biocapital invests in NeuVasQ: EUR 20 million Series A to develop unique blood-brain barrier therapy
– Newton together with public and private investment partners invests in NeuVasQ for the development of blood-brain barrier pharmaceuticals based […] June 22, 2021 · Turnstone Communications
Article
Malaria vaccine candidate shows promise for African children
Despite decades of research, scientists have so far been unable to develop a fully effective vaccine for malaria. Now, a […] June 16, 2021 · BioVox
Article
SciMingo: bringing science to the center stage
The world needs more quality science communication. The value to society is evident, as clear communication is key to science-based […] June 16, 2021 · SciMingoMontis Biosciences Awarded VLAIO Grant to Expand its Pipeline of Novel Immune-Oncology Therapeutics
Leuven, Belgium, 14 June 2021 – Montis Biosciences, a Belgium-based biotech company focused on the development of novel immuno-oncology therapeutics targeting the […] June 14, 2021 · Turnstone Communications
Article
Trusting gut bacteria: MRM Health develops microbiome treatments for IBD and more
In the last decade, there has been a growing interest in the potential of microbiome-based therapeutics: using gut bacteria as […] May 19, 2021 · BioVoxGround-breaking Flemish health projects go virtual: Smart Hub Flemish Brabant launches Health Experience
Smart Hub Flemish Brabant has launched the innovative online platform ‘Health Experience’. The virtual tour gives exclusive insights into the […] May 18, 2021 · Turnstone CommunicationsDroia Ventures raises a new fund of EUR 220 million to target genetic diseases and expands leadership team with George Golumbeski
Brussels, Belgium, 11 May 2021 – Droia Ventures today announced the final closing of its third fund, having raised EUR […] May 11, 2021 · Turnstone CommunicationsPulsify Medical closes second round Series A funding of EUR 6.35 million for wearable ultrasound heart monitor patch
Pulsify Medical is developing wearable ultrasound patches to monitor vital human organs such as the heart. The company has announced […] May 4, 2021 · Turnstone Communications
Article
Belgian pharma industry among the EU’s strongest despite pandemic setbacks
How did the Belgian chemical and pharmaceutical sector fare during the first year of the pandemic? A report from essenscia […] April 28, 2021 · BioVox
Article
To fund or not to fund: the psychology of investment decisions
Much has been written about the psychology of decision making and how venture capitalists choose which companies they want to […] April 28, 2021 · V-Bio Ventures
Article
Beer, bread and bioethanol: SUPERYEAST project to improve industry sustainability
Prof. Kevin Verstrepen, of the VIB-KU Leuven Center for Microbiology, has received a prestigious ERC Proof of Concept grant for […] April 28, 2021 · BioVox
Article
Antwerp start-up to convert CO2 into industry building blocks
The University of Antwerp spin-off D-CRBN is helping carbon-emitting industries transform greenhouse gases into useful products. Using plasma technology, the […] April 28, 2021 · BioVoxProteomics PharmaFluidics Launches Next Generation µPAC™ Technology for Routine Proteomics
Microfluidic chips for use in high-resolution nanoLC/MS workflows Ghent, Belgium, 27 April 2021 – PharmaFluidics NV, innovative life sciences instruments […] April 27, 2021 · Turnstone CommunicationsV-Bio Ventures invests in new start-up Protealis to uplift sustainable plant protein production
Ghent, Belgium, 8 April 2021 – Today V-Bio Ventures announces its investment in Ghent-based company Protealis, a new spin-off from […] April 8, 2021 · V-Bio Ventures
Article
AgomAb’s journey of growth in regenerative medicine
Ghent-based AgomAb Therapeutics recently raised a Series B of $74 million, the largest round ever for a Belgian biotech in […] March 31, 2021 · V-Bio Ventures
Article
Soy in 1000 gardens: citizen science project to map soil microbes in Flanders
Good science takes many hands. In the case of a new citizen science project by VIB, UGent, ILVO, KU Leuven, […] March 31, 2021 · BioVox
Sponsored
Augustine Therapeutics developing new medicines for neuromuscular diseases
Augustine Therapeutics had a lot of announcements this month: the VIB spin-off just appointed Dr. Sylvain Celanire as CEO, strengthened […] March 31, 2021 · Turnstone Communications
Article
Wallonia to invest in plant-based proteins as meat substitutes
The Walloon region is taking major steps towards becoming an important player in the business of plant-based proteins. In the […] March 31, 2021 · BioVoxMontis Biosciences appoints René Hoet as Chief Scientific Officer
Leuven, Belgium, 31 March 2021 – MONTIS BIOSCIENCES, a discovery stage biotech company focused on the development of novel immuno-oncology therapeutics […] March 31, 2021 · Turnstone CommunicationsAugustine Therapeutics awarded EUR 1.2 million VLAIO research grant to develop new medicines for neuromuscular diseases
Leuven, Belgium, 23 March 2021 – Augustine Therapeutics, a biotech spin-out company from VIB that focuses on the development of […] March 23, 2021 · Turnstone CommunicationsAugustine Therapeutics strengthens Board of Directors and sets up Scientific Advisory Board
Leuven, Belgium, 19th March 2021 – Augustine Therapeutics, a biotech company focused on the development of innovative medicines for rare […] March 19, 2021 · Turnstone CommunicationsAugustine Therapeutics appoints Sylvain Celanire as CEO to accelerate development of innovative medicines for rare neuromuscular diseases
Leuven, Belgium, 18th March 2021 – Augustine Therapeutics, a biotech company focused on the development of innovative medicines for rare […] March 18, 2021 · Turnstone Communications
Sponsored
Lessons learned from COVID-19: how do we prepare for the next pandemic?
Although the crisis has not yet passed, COVID-19 has already taught us many valuable lessons. This past year has tested […] March 10, 2021 · Turnstone Communications
Article
Record-breaking pollen levels linked to increased risk of COVID-19
Increased pollen concentrations are correlated with higher rates of COVID-19. Hot on the heels of record-breaking European pollen counts, this […] March 10, 2021 · BioVox
Article
Saving man’s best friend: Volition blood test allows cheap and easy cancer screenings for dogs
A Belgian invention is revolutionizing cancer diagnostics for dogs by making it possible to screen for two common canine cancers […] March 10, 2021 · BioVoxRejuvenate Biomed Secures EUR 3.2 Million Series A Round to Advance Development of Healthy Aging Products
Heusden-Zolder, Belgium, 2 March 2021 – Rejuvenate Biomed NV (“Rejuvenate”), a biomedical company developing prescription drugs for age-related diseases, announces […] March 2, 2021 · Turnstone Communications
Article